Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JC7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,599
Award facts
- Contract value 100% obligated
- $48,599.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) valued at $48,599.43 with an ultimate completion date of January 2, 2026. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an approximately $1 billion vehicle that serves as the primary pharmaceutical supply mechanism for military and federal healthcare systems through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitive contract awards with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Ozempic, a diabetes medication, exemplifies AmerisourceBergen's role as a critical vendor in federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F9JC7?
SPE2DR26F9JC7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F9JC7 worth?
The government has obligated $48,599 on SPE2DR26F9JC7.
Is contract SPE2DR26F9JC7 an order under another contract?
Yes. SPE2DR26F9JC7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JC7 competed?
The extent of competition for SPE2DR26F9JC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award